Advancing the Future of Cancer Therapies with Nanotechnology
About Us
OncoNano is a clinical-stage oncology company working to transform cancer therapeutics with its proprietary nanotechnology platform.
Technology
OncoNano's ON-BOARD™ polymeric micelle platform is designed to leverage universal tumor targets to precisely deliver anti-tumor payloads to the tumor microenvironment.
Pipeline
OncoNano is developing a differentiated pipeline of novel therapies to tackle cancer's greatest challenges.
News
May 2024
March 2024
April 2024
Contact Us
Headquarters
OncoNano Medicine, Inc.
181 Grand Avenue, Suite 225
Southlake, Texas 76092
info@onconanomed.com